NOV 18, 2021 4:36 AM PST

Is Cannabis Useful for Symptoms of Endometriosis?

Endometriosis is a common gynecologic disorder impacting up to 10% of women of reproductive age in the United States. In this disease, similar tissue to the uterine lining grows in aberrant areas such as the ovaries or bowels. The disorder can cause pain, as well as infertility. Although there is currently no cure for the disease, symptoms can be managed with medication and surgery if needed. Recently, cannabis has been investigated as an agent with the potential to mitigate endometriosis-associated symptoms. 

In October 2021, the results of a retrospective cohort study including 252 participants who self-reported endometriosis were published. Participants self-reported changes in symptoms with cannabis use which included cramps, pelvic pain, gastrointestinal symptoms, and depression. Participants engaged in multiple sessions of cannabis use between April 2017 and February 2020. The method of ingestion seemed to impact treatment effectiveness with inhaled cannabis, demonstrating greater effectiveness for pain, while oral cannabis was more beneficial for mood and gastrointestinal symptoms. Although cannabis appeared effective across all symptoms investigated, gastrointestinal symptoms had the most robust self-reported improvement after cannabis use.

As this study is cross-sectional, a causal relationship between cannabis and endometriosis-associated symptoms cannot be determined. In addition, limitations exist that should be considered when reviewing the results. These limitations include the influence of potential bias due to the self-reported nature of both the diagnosis of endometriosis and symptom relief with cannabis use. Nevertheless, these findings are suggestive of a possible association between cannabis use and symptom relief. Therefore, this study supports the value of developing future clinical trials to investigate the use of cannabis for treating endometriosis-associated symptoms.

Source: Johns Hopkins Medicine, CDC, PLOS ONE

About the Author
  • Dr. Christopher DiMaio is a Science Writer at Labroots. He received his MD from Penn State College of Medicine in 2014. His academic and professional interests include Neuroscience, Behavioral health, Immunology, and Healthcare improvement, among others. He is an active part of his community.
You May Also Like
JUL 08, 2021
Health & Medicine
Cannabinoid Hyperemesis Syndrome Is Helped by Hot Pepper Cream
JUL 08, 2021
Cannabinoid Hyperemesis Syndrome Is Helped by Hot Pepper Cream
A new research review suggests that capsaicin cream, rubbed into the abdomen, may help with the symptoms of cannabinoid ...
JUL 08, 2021
Cannabis Sciences
High-potency Cannabis Impacts Memory, but not Decision-Making
JUL 08, 2021
High-potency Cannabis Impacts Memory, but not Decision-Making
High-potency cannabis products impair memory in various ways, according to new research published in Scientific Rep ...
SEP 23, 2021
Cannabis Sciences
Inflammatory Bowel Disease and Cannabis- A Quality of Life Question
SEP 23, 2021
Inflammatory Bowel Disease and Cannabis- A Quality of Life Question
Inflammatory Bowel Disease (IBD) is a term used to describe chronic inflammation of the gastrointestinal tract. In gener ...
OCT 08, 2021
Cannabis Sciences
Research on Cannabis Patches and Topical Lotions to Manage Symptoms of Parkinson's Disease
OCT 08, 2021
Research on Cannabis Patches and Topical Lotions to Manage Symptoms of Parkinson's Disease
As medical cannabis becomes legalized around the globe, patients need to explore which routes of cannabis delivery best ...
NOV 19, 2021
Health & Medicine
Increase in Cannabis Use Disorder in Prenatal Hospitalizations
NOV 19, 2021
Increase in Cannabis Use Disorder in Prenatal Hospitalizations
A recent study by Columbia University and Weill Cornell Medicine researchers found that cannabis use disorder (CUD) in p ...
NOV 24, 2021
Cannabis Sciences
Can Cannabis Treat Chemotherapy-induced Peripheral Neuropathy?
NOV 24, 2021
Can Cannabis Treat Chemotherapy-induced Peripheral Neuropathy?
Platinum-based chemotherapies such as oxaliplatin are used to treat gastrointestinal tumors, especially in the advanced ...
Loading Comments...